春立医疗
(688236)
| 流通市值：11.66亿 | | | 总市值：56.38亿 |
| 流通股本：7929.47万 | | | 总股本：3.84亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 805,857,022.19 | 508,283,661.62 | 380,130,570.92 | 221,850,180.79 |
| 营业收入 | 805,857,022.19 | 508,283,661.62 | 380,130,570.92 | 221,850,180.79 |
| 二、营业总成本 | 678,243,060.18 | 449,469,327.29 | 304,028,844.65 | 164,450,441.62 |
| 营业成本 | 268,952,851.12 | 156,043,170.05 | 108,247,815.46 | 58,041,719.59 |
| 税金及附加 | 7,723,578.58 | 6,012,961.59 | 4,342,874.75 | 1,832,378.18 |
| 销售费用 | 240,247,102.81 | 163,464,944.14 | 111,481,168.8 | 63,145,976.61 |
| 管理费用 | 45,290,473.71 | 31,357,332.9 | 21,310,062.04 | 7,522,645.72 |
| 研发费用 | 133,096,848.59 | 99,676,406.7 | 67,659,413.06 | 34,991,868.71 |
| 财务费用 | -17,067,794.63 | -7,085,488.09 | -9,012,489.46 | -1,084,147.19 |
| 其中:利息费用 | 44,939.07 | 27,847.25 | 27,050.23 | - |
| 其中:利息收入 | 16,309,711.03 | 8,960,596.25 | 8,040,034.97 | 1,263,505.11 |
| 加:公允价值变动收益 | 9,434,830.14 | 6,079,575.33 | 4,670,205.47 | 1,380,799.84 |
| 加:投资收益 | 10,980,482.17 | 9,122,896.79 | 6,084,909.58 | 3,286,525.21 |
| 资产处置收益 | 39,213.61 | 39,213.61 | 39,213.61 | - |
| 资产减值损失(新) | -33,776,793.41 | -9,409,707.93 | -5,229,285.17 | -26,245.26 |
| 信用减值损失(新) | -4,186,610.52 | -7,060,926.86 | -5,794,060.61 | -5,451,806.83 |
| 其他收益 | 20,609,609.96 | 7,865,268.9 | 6,413,483.27 | 2,736,455.16 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 130,714,693.96 | 65,450,654.17 | 82,286,192.42 | 59,325,467.29 |
| 加:营业外收入 | 987,389.36 | 870,286.2 | 856,684.38 | 856,134.36 |
| 减:营业外支出 | 102,914.25 | 156,306.21 | 72,914.25 | 17,033 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 131,599,169.07 | 66,164,634.16 | 83,069,962.55 | 60,164,568.65 |
| 减:所得税费用 | 6,937,885.57 | 5,155,985.69 | 4,109,067.77 | 5,057,505.44 |
| 六、净利润 | 124,661,283.5 | 61,008,648.47 | 78,960,894.78 | 55,107,063.21 |
| 持续经营净利润 | 124,661,283.5 | 61,008,648.47 | 78,960,894.78 | 55,107,063.21 |
| 归属于母公司股东的净利润 | 124,988,009.59 | 61,151,445.55 | 79,026,078.82 | 55,199,616.28 |
| 少数股东损益 | -326,726.09 | -142,797.08 | -65,184.04 | -92,553.07 |
| (一)基本每股收益 | 0.33 | 0.16 | 0.21 | 0.14 |
| (二)稀释每股收益 | 0.33 | 0.16 | 0.21 | 0.14 |
| 九、综合收益总额 | 124,661,283.5 | 61,008,648.47 | 78,960,894.78 | 55,107,063.21 |
| 归属于母公司股东的综合收益总额 | 124,988,009.59 | 61,151,445.55 | 79,026,078.82 | 55,199,616.28 |
| 归属于少数股东的综合收益总额 | -326,726.09 | -142,797.08 | -65,184.04 | -92,553.07 |
| 公告日期 | 2025-03-29 | 2024-10-31 | 2024-08-31 | 2024-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |